PLx Pharma Winddown

PLx Pharma was a specialty pharmaceutical company focused on the development and commercialization of its proprietary PLxGuard drug delivery platform. The technology was designed to improve the gastrointestinal safety and efficacy of various active pharmaceutical ingredients, most notably aspirin. The company's lead product, Vazalore, received FDA approval as the first liquid-filled aspirin capsule for cardiovascular disease prevention and pain relief. Despite the commercial launch, the company faced significant financial challenges and filed for Chapter 11 bankruptcy in April 2023. Subsequently, the company sold its assets, including the Vazalore brand, to Apotheca Support Services and transitioned into a wind-down phase to liquidate remaining holdings.